University Health Network, Toronto
Clinical trials sponsored by University Health Network, Toronto, explained in plain language.
-
Dravet drug trial halted early: hope for seizure control remains unproven
Disease control TerminatedThis study tested the drug fenfluramine (FINTEPLA) in adults with Dravet syndrome whose seizures were not controlled by other medications. The goal was to see if adding fenfluramine could cut monthly seizures by at least half. The trial was terminated early and enrolled only 7 pa…
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 26, 2026 03:08 UTC
-
Chemotherapy-Free hope for advanced lung cancer falls short
Disease control TerminatedThis study tested two immunotherapy drugs, nivolumab and ipilimumab, for people with advanced non-small cell lung cancer that had spread. The goal was to see if this drug combination could control the cancer without needing chemotherapy. Only 5 people took part before the study w…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 26, 2026 03:06 UTC
-
Cancer and COVID: study probes hidden infections
Knowledge-focused TerminatedThis study looked at how COVID-19 impacts people with cancer. Researchers measured how many cancer patients had COVID-19 without symptoms and how their immune systems responded. The study included 83 participants but was stopped early.
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 26, 2026 03:01 UTC